Difficulty: Medium
Average Score: 64%
Practice
The Coronary Primary Prevention Trial (CPPT) demonstrated that treatment with a lipid-lowering drug could reduce the risk of death due to coronary heart disease. This consideration is:
Correct answer
A
Rationale
The correct answer is A) TRUE. The Coronary Primary Prevention Trial (CPPT) did indeed demonstrate that treatment with a lipid-lowering drug could reduce the risk of death due to coronary heart disease. This is a crucial finding because it provides evidence of the effectiveness of pharmacological interventions in preventing a significant cause of mortality. Lipid-lowering drugs, such as statins, have been shown to reduce cholesterol levels and subsequently decrease the risk of cardiovascular events like heart attacks and strokes.
Option B) FALSE is incorrect because the CPPT results did support the effectiveness of pharmacological treatments in reducing the risk of death from coronary heart disease. Option C) None is incorrect as there is a definitive answer supported by research. Option D) All the above is incorrect because only option A is true in this context.
From an educational perspective, understanding the outcomes of landmark trials like the CPPT is essential for healthcare professionals, especially those involved in managing cardiovascular health. It highlights the importance of evidence-based medicine and the role of pharmacological treatments in improving patient outcomes. This knowledge can guide clinical decision-making and enhance the quality of care provided to clients across the lifespan.
Option B) FALSE is incorrect because the CPPT results did support the effectiveness of pharmacological treatments in reducing the risk of death from coronary heart disease. Option C) None is incorrect as there is a definitive answer supported by research. Option D) All the above is incorrect because only option A is true in this context.
From an educational perspective, understanding the outcomes of landmark trials like the CPPT is essential for healthcare professionals, especially those involved in managing cardiovascular health. It highlights the importance of evidence-based medicine and the role of pharmacological treatments in improving patient outcomes. This knowledge can guide clinical decision-making and enhance the quality of care provided to clients across the lifespan.